Alnylam Pharmaceuticals, Inc.

VANGUARD GROUP INC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

13,553,932

Value ($000)

5,389,721

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	5,389,721	0.1%	13,553,932	12/31/2025
2025 Q3	11/7/2025	6,185,846	0.1%	13,565,452	9/30/2025
2025 Q2	8/11/2025	4,336,064	0.1%	13,297,139	6/30/2025
2025 Q1	5/9/2025	3,525,544	0.1%	13,056,605	3/31/2025
2024 Q4	2/11/2025	2,996,296	0.1%	12,733,399	12/31/2024
2024 Q3	11/13/2024	3,475,030	0.1%	12,635,096	9/30/2024
2024 Q2	8/13/2024	3,039,390	0.1%	12,507,778	6/30/2024
2024 Q1	5/10/2024	1,792,542	0.0%	11,994,261	3/31/2024
2023 Q4	3/11/2024	2,286,181	0.0%	11,943,895	12/31/2023
2023 Q3	12/18/2023	2,064,425	0.1%	11,656,831	9/30/2023
2023 Q2	8/14/2023	2,208,285	0.1%	11,626,223	6/30/2023
2023 Q1	7/14/2023	2,325,348	0.1%	11,608,167	3/31/2023
2022 Q4	2/10/2023	2,734,666	0.1%	11,507,116	12/31/2022
2022 Q3	11/14/2022	2,212,429	0.1%	11,053,308	9/30/2022
2022 Q2	8/12/2022	1,610,540	0.0%	11,042,438	6/30/2022
2022 Q1	5/13/2022	1,768,291	0.0%	10,829,144	3/31/2022
2021 Q4	2/14/2022	1,814,977	0.0%	10,702,771	12/31/2021
2021 Q3	11/12/2021	2,004,140	0.0%	10,614,582	9/30/2021
2021 Q2	8/13/2021	1,779,569	0.0%	10,497,694	6/30/2021
2021 Q1	5/14/2021	1,494,611	0.0%	10,585,821	3/31/2021
2020 Q4	2/12/2021	1,368,119	0.0%	10,526,424	12/31/2020
2020 Q3	11/16/2020	1,533,489	0.1%	10,532,206	9/30/2020
2020 Q2	8/14/2020	1,614,574	0.1%	10,901,184	6/30/2020
2020 Q1	5/15/2020	1,147,910	0.0%	10,545,805	3/31/2020
2019 Q4	2/14/2020	1,184,808	0.0%	10,287,472	12/31/2019
2014 Q2	8/11/2014	207,003	0.0%	3,276,926	6/30/2014
2014 Q1	5/13/2014	180,041	0.0%	2,681,576	3/31/2014
2013 Q4	2/12/2014	190,883	0.0%	2,967,253	12/31/2013